3+ day, 12+ hour ago   (159+ words) PharmaDispatch Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence A Sydney company has become the first in Australia to earn a manufacturing licence for viral vectors, a milestone it says strengthens the nation's capacity to make advanced…...

1+ week, 6+ day ago   (140+ words) PharmaDispatch Alterity secures option underwriting as it prepares for pivotal MSA trial Alterity Therapeutics has secured an underwriting agreement that could provide at least $4.2 million in additional funding as the company prepares to begin its planned Phase 3 clinical trial of…...

1+ week, 6+ day ago   (131+ words) PharmaDispatch Astellas Australia turns to rare disease leader Guillaume Pfeiffer for next chapter Astellas Australia has appointed Guillaume Pfeiffer as its new general manager, bringing more than two decades of experience across specialty medicines, rare diseases, oncology and advanced therapies…...

2+ week, 4+ day ago   (142+ words) PharmaDispatch Genetic Signatures and Microba explore merger to build infectious disease diagnostics group Genetic Signatures and Microba Life Sciences have announced they are in preliminary discussions about a potential merger that would combine rapid infectious disease testing with gut microbiome…...

3+ week, 5+ day ago   (136+ words) PharmaDispatch Opportunity #1 - biosimilar policy failure has become impossible to ignore If the promise of biosimilars is only savings for the government, rather than savings and wider access, what is the point from a patient perspective? The one-dimensional focus on savings…...

1+ mon, 4+ day ago   (115+ words) PharmaDispatch Australia’s 'Biggest Week in Biotech' brings global life sciences leaders to the Gold Coast AusBiotech has unveiled the integrated program for the 2026 AusBiotech International Conference and AusMedtech Conference, bringing more than 250 speakers together across approximately 60 sessions on the Gold…...

1+ mon, 1+ week ago   (119+ words) PharmaDispatch Australian company announces agreement with Lilly to trial lung cancer combination The Australian company had already worked with Lilly to prepare an advanced draft of the clinical study protocol before signing the significant agreement. … The HTA Review and the…...

1+ mon, 2+ week ago   (146+ words) PharmaDispatch Helping to build Australia’s life sciences future at Brisbane’s innovation junction Professor Trent Munro, General Manager of the BRIJ, and Rebekah Cassidy, CEO of AusBiotech, spoke with BioPharmaDispatch-BPDInsights about the precinct’s contribution to how Australia’s life sciences sector is…...

2+ mon, 5+ day ago   (146+ words) PharmaDispatch Illumina taps medtech leader to head Australia and New Zealand operations Illumina has appointed Susan Martin as General Manager for Australia and New Zealand, strengthening the company’s regional leadership as it pushes to integrate genomics more broadly into clinical…...

2+ mon, 1+ week ago   (140+ words) PharmaDispatch Early clinical imaging shows Syntara candidate reduces brain inflammation in people at high risk of Parkinson’s Australian company Syntara and Parkinson’s Research Ventures have reported early signs that a novel anti-inflammatory candidate may reduce brain inflammation in people at…...